Shopping for the outdoor adventurer in your life can feel intimidating. Seasoned adventurers tend to be picky about gear and ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported net income of $27.9 million in its third quarter. On a per-share basis, the ...

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on ...

CEO Raul Rodriguez highlighted, “For the third quarter, we reported total revenue of $69.5 million, including record net product sales of $64.1 million, a 65% year-over-year increase.” He noted that ...

Based on the one-year price targets offered by 6 analysts, the average target price for Rigel Pharmaceuticals Inc (NASDAQ:RIGL) is $38.33, with a high estimate of $67.00 and a low estimate of $23.00.